logo
#

Latest news with #JennyAhlstrom

Sandy mom of six survives 15 years of blood cancer, helps other patients fight
Sandy mom of six survives 15 years of blood cancer, helps other patients fight

Yahoo

time27-05-2025

  • General
  • Yahoo

Sandy mom of six survives 15 years of blood cancer, helps other patients fight

SANDY, Utah () — A mom who fought, and won, a 15-year fight with blood cancer, created a nonprofit to ensure others battling cancer have a fighting chance, too. Jenny Ahlstrom, 57, was diagnosed with , a form of blood cancer, in 2010. Following her diagnosis, she was presented with a lot of options for treatment. 'It's really hard to figure out, as a patient, what to do,' Ahlstrom told ABC4. 'I was looking for strategies where I could get treated and not have to be treated for a long time.' A turning point in Ahlstrom's battle was receiving a known as CAR-T during clinical trials. The treatment, much like dialysis, included the removal of her blood cells, changing them in a lab, then infusing the cells back into her through an IV drip. 'Taking care of Jenny and taking care of her family… has just been remarkable,' Ahlstrom's doctor, Doug Sborov, said. 'Blessed and grateful': Teen survivor of West Valley murder-suicide graduates high school According to Sborov, an Associate Professor at the University of Utah's Huntsman Cancer Institute, multiple myeloma is generally considered to be 'incurable.' However, with new research and medications, like CAR-T, physicians can drastically lengthen patients' lives and improve their quality of life. 'Here I am, three years later, completely disease free,' Ahlstrom said. 'She's provided patients an incredible opportunity to be educated. She's provided researchers, like myself, an incredible opportunity to engage with patients and really fundamentally change how we're approaching how we take care of these folks,' Sborov told ABC4. Jenny Ahlstrom raises awareness about available resources for blood cancer patients. (Courtesy Stacey Isaacs) Now, Ahlstrom leads a nonprofit called that raises awareness and increases access to vital data for researchers. 'If we're going to make advances in healthcare, we need to leapfrog forward in innovation,' Ahlstrom said. Ahlstrom says there are about 35,000 new diagnoses of myeloma every year and 150,000 living patients with myeloma. 'It's really amazing to bring these new types of therapy to these patients,' Ahlstrom said. 'It's available and it's here.' Trump to pardon reality TV stars Todd and Julie Chrisley Sandy mom of six survives 15 years of blood cancer, helps other patients fight Orem woman allegedly blocks driver, causing 'significant congestion' during road rage incident RFK Jr. ends COVID shot recommendation for healthy kids, pregnant women President Trump appears to lose patience with Putin Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Remarkable Utah woman leads charge to find cure for cancer
Remarkable Utah woman leads charge to find cure for cancer

Yahoo

time12-03-2025

  • Health
  • Yahoo

Remarkable Utah woman leads charge to find cure for cancer

SOUTH JORDAN, Utah (Good Things Utah) – Throughout Women's History Month (March) ABC4-CW30 (Good4Utah) is sharing the stories of remarkable women who contribute their time, talent, and treasure to help others and lift the community. Every Tuesday, on Good Things Utah (9a-10a) and on , we share another remarkable woman's story. This week we introduce you to Jenny Ahlstrom – a mom of six, a wife, a women in tech, a cancer patient, and a ground-breaking entrepreneur and non-profit founder working to save lives – including here own – by improving peoples' access to helpful cancer support services, information and life-saving research. Jenny Ahlstrom is the Founder and CEO of Healthtree Foundation based in South Jordan, Utah. Learn more about our Remarkable Women Campaign here. Close Thanks for signing up! Watch for us in your inbox. Subscribe Now Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Inc. Names HealthTree CEO Jenny Ahlstrom to Its 2025 Female Founders 500 List
Inc. Names HealthTree CEO Jenny Ahlstrom to Its 2025 Female Founders 500 List

Yahoo

time11-03-2025

  • Business
  • Yahoo

Inc. Names HealthTree CEO Jenny Ahlstrom to Its 2025 Female Founders 500 List

Inc.'s eighth annual Female Founders list highlights the nation's top business leaders who challenge the status quo to tackle some of the world's biggest problems SALT LAKE CITY, March 11, 2025 /PRNewswire/ -- Inc., the leading media brand and playbook for the entrepreneurs and business leaders shaping our future, today announced its eighth annual Female Founders list, honoring HealthTree CEO and Founder Jenny Ahlstrom in the bold group of 500 women whose innovations and ideas are leading their industries forward. Each year, Inc. editors review thousands of applications highlighting female founders and applicants through three rounds of judging, looking specifically at an entrepreneur's accomplishments in the past year. Criteria include quantifiable metrics such as revenue, sales, revenue growth, funding, and audience size. Inc. also looks for qualitative metrics including social media momentum and stories of impact. Applicants are additionally evaluated through the program's advisory board. "I'm honored to be recognized as an Inc. Female Founder 500 for my work at HealthTree," said Ahlstrom. "We are revolutionizing cancer research by using technology that links patients and their data with researchers for faster cures. Providing patients with tools that enable them to become cure contributors is the future of personalized medicine." Restricted access to complete and accurate patient data slows cancer research. HealthTree overcomes these challenges by empowering patients with tools to provide researchers with complete, longitudinal data. HealthTree overcomes traditional research barriers with its direct-to-patient model, building long-term relationships of trust with patients through its comprehensive programs. As a multiple myeloma patient herself, Ahlstrom understands deeply the challenges facing those with a cancer diagnosis. Under her leadership, HealthTree has become the market leader in Digital Health Advocacy, expanding its programs and software platform of over 14 integrated technology tools to support all cancers. "Female founders know what struggle is, but they're also experts of improvisation, adaptability, and creativity. The women featured on this year's list exemplify these qualities. Through times of uncertainty, their unwavering dedication and steadfast leadership are not only inspiring but vital to driving progress," said Inc. executive editor Diana Ransom. To see the complete list of honorees, please visit: About is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit About HealthTree FoundationHealthTree Foundation is a global nonprofit organization dedicated to improving outcomes and finding cures for blood cancers through cutting-edge technology, patient education, and research collaboration. The foundation's HealthTree Cure Hub Registry provides a powerful patient data portal where over 10,000 patients contribute real-world data, enabling researchers to drive lifesaving discoveries. By uniting patients and researchers, HealthTree is revolutionizing cancer care and accelerating cures. For more information, visit View original content to download multimedia: SOURCE HealthTree Foundation Sign in to access your portfolio

HealthTree introduces AI-powered tool to match myeloma patients with trials
HealthTree introduces AI-powered tool to match myeloma patients with trials

Yahoo

time04-03-2025

  • Health
  • Yahoo

HealthTree introduces AI-powered tool to match myeloma patients with trials

The HealthTree Foundation has announced the launch of the new AI-powered personalised Clinical Trial Finder, designed to match multiple myeloma (MM) patients with suitable trials. This feature, now part of the HealthTree Cure Hub Registry, leverages AI to enhance the process of connecting subjects with potential treatment options in clinical trials depending on their medical records. HealthTree Foundation CTO Juan Pablo Capdevila said: "We are able to power the HealthTree Clinical Trial Finder with clean, validated, and organised data thanks to our use of AI. "This enables real-time analysis of the data against continuously updated trial databases for instant matching." For individuals with MM, the task of locating a relevant clinical trial can be time-consuming due to the complexity of trial eligibility criteria. The HealthTree Clinical Trial Finder aims to alleviate this challenge by individual medical records analysis, which includes laboratory values, disease markers and treatment history, to identify trials for which a patient is eligible. According to the organisation, this service not only helps subjects explore all available treatment avenues but also streamlines the search time for clinicians and expedites the enrolment process for studies, potentially speeding up the discovery of new cures. HealthTree Founder and CEO Jenny Ahlstrom said: "This is the first truly personalised clinical trial finder. Unlike common clinical trial finders that allow patients to search for trials based on filters like zip code or treatment type, we are using tens of thousands of data points to ensure that patients receive personalised trial matches based on their real-world medical data." A non-profit organisation, the HealthTree Foundation is focused on enhancing outcomes and discovering cures for blood cancers via patient education, research partnership, and technology. The organisation's HealthTree Cure Hub is a data portal of patients, which has gathered real-world data from over 10,000 individuals, thereby allowing researchers to make advances in the field. "HealthTree introduces AI-powered tool to match myeloma patients with trials" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store